# | Title | Journal | Year | Citations |
---|
1 | The Subgenual Anterior Cingulate Cortex in Mood Disorders | CNS Spectrums | 2008 | 920 |
2 | Mild Cognitive Impairment:An Overview | CNS Spectrums | 2008 | 548 |
3 | Light Therapy for Seasonal and Nonseasonal Depression: Efficacy, Protocol, Safety, and Side Effects | CNS Spectrums | 2005 | 435 |
4 | SNRIs: The Pharmacology, Clinical Efficacy, and Tolerability in Comparison with Other Classes of Antidepressants | CNS Spectrums | 2005 | 409 |
5 | Functional Neuroimaging Studies of Human Emotions | CNS Spectrums | 2004 | 402 |
6 | New developments in human neurocognition: clinical, genetic, and brain imaging correlates of impulsivity and compulsivity | CNS Spectrums | 2014 | 394 |
7 | Freeze, Flight, Fight, Fright, Faint: Adaptationist Perspectives on the Acute Stress Response Spectrum | CNS Spectrums | 2004 | 369 |
8 | Food and Drug Administration Regulation | CNS Spectrums | 2008 | 362 |
9 | Mechanism of Action of Trazodone:a Multifunctional Drug | CNS Spectrums | 2009 | 357 |
10 | The Prevalence of Body Dysmorphic Disorder in the United States Adult Population | CNS Spectrums | 2008 | 333 |
11 | The neurobiology of aggression and violence | CNS Spectrums | 2015 | 313 |
12 | The Neurobiology of Substance and Behavioral Addictions | CNS Spectrums | 2006 | 307 |
13 | The Precuneus and Consciousness | CNS Spectrums | 2007 | 302 |
14 | Hot and cold cognition in depression | CNS Spectrums | 2013 | 287 |
15 | Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorder | CNS Spectrums | 2015 | 270 |
16 | Inflammation, Glutamate, and Glia in Depression:A Literature Review | CNS Spectrums | 2008 | 261 |
17 | Long-Term, Open-Label Extension Study of Guanfacine Extended Release in Children and Adolescents with ADHD | CNS Spectrums | 2008 | 256 |
18 | The role of reproductive hormones in postpartum depression | CNS Spectrums | 2015 | 256 |
19 | Beyond Monoamines: Glutamatergic Function in Mood Disorders | CNS Spectrums | 2005 | 254 |
20 | Aripiprazole Augmentation in Major Depressive Disorder: A Double-Blind, Placebo-Controlled Study in Patients with Inadequate Response to Antidepressants | CNS Spectrums | 2009 | 254 |
21 | Conceptually Driven Pharmacologic Approaches to Acute Trauma | CNS Spectrums | 2005 | 236 |
22 | Potential Markers for Problematic Internet Use: A Telephone Survey of 2,513 Adults | CNS Spectrums | 2006 | 235 |
23 | Psychiatric Comorbidity of Internet Addiction in College Students: An Interview Study | CNS Spectrums | 2008 | 230 |
24 | Selective Histamine H1 Antagonism: Novel Hypnotic and Pharmacologic Actions Challenge Classical Notions of Antihistamines | CNS Spectrums | 2008 | 228 |
25 | State of the science on mild cognitive impairment (MCI) | CNS Spectrums | 2019 | 228 |
26 | The Interplay of Neurotransmitters in Alzheimer's Disease | CNS Spectrums | 2005 | 217 |
27 | A Virtual Reality Scenario for All Seasons:The Virtual Classroom | CNS Spectrums | 2009 | 213 |
28 | Risk of Recurrence of Depression During Long-Term Antidepressant Treatment | CNS Spectrums | 2007 | 211 |
29 | Mechanism of action of pimavanserin in Parkinson’s disease psychosis: targeting serotonin 5HT2A and 5HT2C receptors | CNS Spectrums | 2016 | 210 |
30 | Drugs for psychosis and mood: unique actions at D3, D2, and D1 dopamine receptor subtypes | CNS Spectrums | 2017 | 210 |
31 | Reassessing Carbamazepine in the Treatment of Bipolar Disorder Clinical Implications of New Data | CNS Spectrums | 2005 | 197 |
32 | The Role of Glutamate in Anxiety and Related Disorders | CNS Spectrums | 2005 | 196 |
33 | Abuse and Neglect in Childhood: Relationship to Personality Disorder Diagnoses | CNS Spectrums | 2003 | 193 |
34 | Mechanism of action of agomelatine: a novel antidepressant exploiting synergy between monoaminergic and melatonergic properties | CNS Spectrums | 2014 | 191 |
35 | Forgotten but not gone: new developments in the understanding and treatment of tardive dyskinesia | CNS Spectrums | 2016 | 191 |
36 | Converting oral to long-acting injectable antipsychotics: a guide for the perplexed | CNS Spectrums | 2017 | 191 |
37 | Neurobiology of posttraumatic stress disorder | CNS Spectrums | 2009 | 191 |
38 | Cariprazine efficacy in bipolar I depression with and without concurrent manic symptoms: post hoc analysis of 3 randomized, placebo-controlled studies | CNS Spectrums | 2020 | 178 |
39 | New Pharmacotherapeutic Approaches to Obsessive-Compulsive Disorder | CNS Spectrums | 2009 | 177 |
40 | Mechanism of action of tasimelteon in non-24 sleep-wake syndrome: treatment for a circadian rhythm disorder in blind patients | CNS Spectrums | 2014 | 176 |
41 | Psychiatric Comorbidity in 36 Adults with Mitochondrial Cytopathies | CNS Spectrums | 2007 | 174 |
42 | Long-term effects of cariprazine exposure on dopamine receptor subtypes | CNS Spectrums | 2014 | 172 |
43 | The Shorter PROMIS Questionnaire and the Internet Addiction Scale in the Assessment of Multiple Addictions in a High-School Population:Prevalence and Related Disability | CNS Spectrums | 2006 | 170 |
44 | Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate | CNS Spectrums | 2018 | 170 |
45 | Defining and Diagnosing Involuntary Emotional Expression Disorder | CNS Spectrums | 2006 | 168 |
46 | Expanding the definition of addiction: DSM-5 vs. ICD-11 | CNS Spectrums | 2016 | 167 |
47 | Sensory Phenomena in Obsessive-Compulsive Disorder and Tic Disorders: A Review of the Literature | CNS Spectrums | 2008 | 162 |
48 | Keeping Up with Clinical Advances: Opioid Use Disorder | CNS Spectrums | 2019 | 161 |
49 | Mixed Amphetamine Salts Extended-Release in the Treatment of Adult ADHD:A Randomized, Controlled Trial | CNS Spectrums | 2006 | 160 |
50 | Suicide in Bipolar Disorder: Risks and Management | CNS Spectrums | 2006 | 160 |